179 related articles for article (PubMed ID: 26273683)
21. Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement.
Wada Y; Kuroda T; Murasawa A; Nakano M; Narita I
Mod Rheumatol; 2010 Jun; 20(3):252-6. PubMed ID: 20107854
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of BPI-ANCA detecting in COPD patients with Pseudomonas aeruginosa colonization.
Tian Y; Zeng T; Tan L; Wu Y; Yu J; Huang J; Pei Z
J Clin Lab Anal; 2019 Jul; 33(6):e22908. PubMed ID: 31106488
[TBL] [Abstract][Full Text] [Related]
23. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
24. The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.
Skopelja S; Hamilton BJ; Jones JD; Yang ML; Mamula M; Ashare A; Gifford AH; Rigby WF
JCI Insight; 2016 Oct; 1(17):e88912. PubMed ID: 27777975
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
26. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
Cobanoğlu N; Ozcelik U; Cetin I; Yalçin E; Doğru D; Kiper N; Bakkaloğlu A
Turk J Pediatr; 2010; 52(4):343-7. PubMed ID: 21043377
[TBL] [Abstract][Full Text] [Related]
27. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of BPI-ANCA in patients with primary Sjögren's syndrome are associated with lung involvement.
Wu Y; Yang Y; Qin Y; Wang Y; Feng M; Zhao X; Liang Z; Zhang C; Liu G; Guo H; Luo J
Clin Biochem; 2020 Sep; 83():43-48. PubMed ID: 32502475
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
[TBL] [Abstract][Full Text] [Related]
30. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.
Cooper T; Savige J; Nassis L; Paspaliaris B; Neeson P; Neil J; Knight KR; Daskalakis M; Doery JC
Rheumatol Int; 2000; 19(4):129-36. PubMed ID: 10836522
[TBL] [Abstract][Full Text] [Related]
31. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.
Schultz H; Schinke S; Weiss J; Cerundolo V; Gross WL; Gadola S
Clin Exp Immunol; 2003 Aug; 133(2):252-9. PubMed ID: 12869032
[TBL] [Abstract][Full Text] [Related]
32. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
Schultz H
Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
[TBL] [Abstract][Full Text] [Related]
33. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia.
Theprungsirikul J; Thaden JT; Wierzbicki RM; Burns AS; Skopelja-Gardner S; Fowler VG; Winthrop KL; Martin IW; Rigby WFC
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747603
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against bactericidal/permeability-increasing protein (BPI) in children with acute pneumonia.
Steiner P; Otth M; Casaulta C; Aebi C
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):125-8. PubMed ID: 19702878
[TBL] [Abstract][Full Text] [Related]
36. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
37. BPI-ANCA in chronic obstructive pulmonary disease with pulmonary Pseudomonas aeruginosa colonisation: a novel indicator of poor prognosis.
Tian Y; Zeng T; Tan L; Wu Y; Yu J; Huang J; Pei Z
Br J Biomed Sci; 2018 Oct; 75(4):206-208. PubMed ID: 30105943
[No Abstract] [Full Text] [Related]
38. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Vecchi M; Sinico A; Bianchi MB; Radice A; Gionchetti P; Campieri M; de Franchis R
Scand J Gastroenterol; 1998 Dec; 33(12):1284-8. PubMed ID: 9930392
[TBL] [Abstract][Full Text] [Related]
39. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
40. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Dassios TG; Katelari A; Doudounakis S; Dimitriou G
Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
